BioPharma Credit PLC Notice of Interim Results (0035Z)
28 August 2018 - 8:20PM
UK Regulatory
TIDMBPCR
RNS Number : 0035Z
BioPharma Credit PLC
28 August 2018
28 August 2018
BIOPHARMA CREDIT PLC
("The Company")
NOTICE OF INTERIM RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, will announce its audited Half Year Results for the
period ending 30 June 2018, on Thursday 27 September 2018.
A management presentation will be delivered at 11:30 through a
conference call facility, to request conference call details, RSVP
to henryw@buchanan.uk.com.
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORKVLBLVVFEBBX
(END) Dow Jones Newswires
August 28, 2018 06:20 ET (10:20 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024